Period of time: 2014年2期
Publisher: Informa Healthcare
Founded in: 1996
Total resources: 42
ISSN: 1472-8214
Subject: R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Emerging Drugs,volume 10,issue 2
Menu
Therapeutic strategies in nonalcoholic fatty liver disorders
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.Emerging drugs for bacterial urinary tract infections
By Wagenlehner Florian ME,Weidner Wolfgang,Naber Kurt G in (2005)
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis
By Haringman Jasper J,Oostendorp Roos L,Tak Paul P in (2005)
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.New antiarrhythmic agents for atrial fibrillation and atrial flutter
By Pecini Redi,Elming Hanne,Pedersen Ole Dyg,Torp-Pedersen Christian in (2005)
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.Development of medications for alcohol use disorders: recent advances and ongoing challenges
By Litten Raye Z,Fertig Joanne,Mattson Margaret,Egli Mark in (2005)
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.Emerging chemotherapeutic strategies for Huntington’s disease
By Ryu Hoon,Ferrante Robert J in (2005)
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.Emerging drugs in Tourette syndrome
By Silay Yavuz S,Jankovic Joseph in (2005)
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.Emerging drugs in cutaneous T-cell lymphomas
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.By Bystryn Jean-Claude,Rudolph Jennifer L in (2005)
Expert Opinion on Emerging Drugs,volume 10,issue 2 , Vol. 10, Iss. 2, 2005-05 , pp.